Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
Open Access
- 1 October 2000
- Vol. 55 (90002) , 28S-31
- https://doi.org/10.1136/thorax.55.suppl_2.s28
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene ReceptorMolecular Pharmacology, 1999
- Biosynthesis of cysteinyl‐leucotrienes in aspirin‐intolerant asthmaClinical and Experimental Allergy, 1999
- Egr-1 and Sp1 Interact Functionally with the 5-Lipoxygenase Promoter and Its Naturally Occurring MutantsAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Leukotriene modifiers in the treatment of asthmaBMJ, 1998
- Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.Journal of Clinical Investigation, 1998
- Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthmaThe Lancet, 1997
- The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma.American Journal of Respiratory and Critical Care Medicine, 1997
- Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.Journal of Clinical Investigation, 1997
- Leukotriene E4 and granulocytic infiltration into asthmatic airwaysThe Lancet, 1993